MedTech Innovator

MedTech Innovator is the largest accelerator of medical devices in the world, renowned for its rigorous and highly selective program designed to advance innovative healthcare technologies. Founded in 2013 by Paul Grand, the organization emerged from a recognized need to bridge the gap between promising medical device startups and the resources, mentorship, and capital required to bring their solutions to market. Its mission is to improve the lives of patients by accelerating the growth of transformative medical technologies. MedTech Innovator operates on an investment thesis centered on identifying high-potential, early to mid-stage medical device, diagnostic, and digital health companies that address significant unmet clinical needs and have strong commercial viability. They do not take equity from participating companies, a distinguishing factor that allows entrepreneurs to retain full ownership while benefiting from the program's extensive network and resources.

Key programs include their flagship annual accelerator, which culminates in a competition for non-dilutive cash prizes at AdvaMed's The MedTech Conference. This program provides intensive mentorship from over 400 industry leaders, including corporate partners, investors, and clinical experts. They also run specialized programs like the Asia Pacific Accelerator and the Pediatric Device Innovation Consortium, focusing on specific regional or therapeutic areas. Geographically, MedTech Innovator has a global reach, with a strong presence in North America, Europe, and Asia Pacific. Their portfolio highlights include numerous companies that have achieved significant milestones, such as successful FDA approvals, strategic partnerships, and substantial funding rounds, ultimately impacting patient care across various disease states. What makes MedTech Innovator stand out is its non-dilutive model, its deep integration with the established medical technology industry, and its commitment to fostering a collaborative ecosystem that truly accelerates the development and adoption of groundbreaking medical innovations.